These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 32133150)

  • 1. Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.
    Park JH; Dehaini D; Zhou J; Holay M; Fang RH; Zhang L
    Nanoscale Horiz; 2020 Jan; 5(1):25-42. PubMed ID: 32133150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects.
    Iverson N; Plourde N; Chnari E; Nackman GB; Moghe PV
    BioDrugs; 2008; 22(1):1-10. PubMed ID: 18215086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic Nanotechnology toward Personalized Vaccines.
    Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
    Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine in cardiovascular therapy: recent advancements.
    Binsalamah ZM; Paul A; Prakash S; Shum-Tim D
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recent applications of nanotechnology in the diagnosis and treatment of common cardiovascular diseases.
    Li F; Shao H; Zhou G; Wang B; Xu Y; Liang W; Chen L
    Vascul Pharmacol; 2023 Oct; 152():107200. PubMed ID: 37500029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology Approaches in Tackling Cardiovascular Diseases.
    Prajnamitra RP; Chen HC; Lin CJ; Chen LL; Hsieh PC
    Molecules; 2019 May; 24(10):. PubMed ID: 31137787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review.
    Tesoro L; Hernandez I; Saura M; Badimón L; Zaragoza C
    Eur J Clin Invest; 2024 Jul; 54(7):e14208. PubMed ID: 38622800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Polymers Influence on Cardiac Health: Good or Bad for Cardiac Physiology?
    Kanithi M; Kumari L; Yalakaturi K; Munjal K; Jimitreddy S; Kandamuri M; Veeramachineni P; Chopra H; Junapudi S
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102145. PubMed ID: 37852559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology and biomimetic methods in therapeutics: molecular scale control with some help from nature.
    Hilt JZ
    Adv Drug Deliv Rev; 2004 Sep; 56(11):1533-6. PubMed ID: 15350287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
    Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.
    Luk BT; Jiang Y; Copp JA; Hu CJ; Krishnan N; Gao W; Li S; Fang RH; Zhang L
    Mol Pharm; 2018 Sep; 15(9):3723-3728. PubMed ID: 29533668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis: A New Horizon of Treatment.
    Lankala CR; Yasir M; Ishak A; Mekhail M; Kalyankar P; Gupta K
    Curr Probl Cardiol; 2023 Jun; 48(6):101671. PubMed ID: 36828044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advancement in the Treatment of Cardiovascular Diseases: Conventional Therapy to Nanotechnology.
    Behera SS; Pramanik K; Nayak MK
    Curr Pharm Des; 2015; 21(30):4479-97. PubMed ID: 26278923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions.
    Sharma I; Bhardwaj S; Karwasra R; Kaushik D; Sharma S
    Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic nanotechnology.
    Takai O
    Ann N Y Acad Sci; 2006 Dec; 1093():84-97. PubMed ID: 17312253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organotropic Targeting of Biomimetic Nanoparticles to Treat Lung Disease.
    Holay M; Zhou J; Park JH; Landa I; Ventura CJ; Gao W; Fang RH; Zhang L
    Bioconjug Chem; 2022 Apr; 33(4):586-593. PubMed ID: 35285617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.